MetaADEDB 2.0 @ LMMD
Ezetimibe, Simvastatin Drug Combination
(PNAMDJVUJCJOIX-IUNFJCKHSA-N)
Structure
SMILES
Oc1ccc(cc1)[C@@H]1[C@@H](CC[C@@H](c2ccc(cc2)F)O)C(=O)N1c1ccc(cc1)F.CCC(C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)(C)C
Molecular Formula:
C49H59F2NO8
Molecular Weight:
827.991
Log P:
9.5389
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
3
TPSA:
133.6
CAS Number(s):
444313-53-5
Synonym(s)
1.
Ezetimibe, Simvastatin Drug Combination
2.
Ezetimibe Simvastatin Drug Combination
3.
Ezetimibe-Simvastatin Combination
4.
Ezetimibe-Simvastatin Drug Combination
5.
Inegy
6.
Vytorin
7.
Combination, Ezetimibe-Simvastatin
8.
Combination, Ezetimibe-Simvastatin Drug
9.
Drug Combination, Ezetimibe-Simvastatin
10.
Ezetimibe Simvastatin Combination
External Link(s)
MeSHD000069499
PubChem Compound9832423
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MyalgiaFAERS: 258US FAERS
2RhabdomyolysisFAERS: 219US FAERS
3PainFAERS: 11719167588CTD
US FAERS
4Blood creatine phosphokinase increasedFAERS: 103US FAERS
5Myocardial InfarctionFAERS: 98US FAERS
6AstheniaFAERS: 83US FAERS
7ArthralgiaFAERS: 81US FAERS
8Cerebrovascular accidentFAERS: 78US FAERS
9AnxietyFAERS: 62US FAERS
10FatigueFAERS: 56US FAERS
11ArteriosclerosisFAERS: 55US FAERS
12No adverse eventFAERS: 55US FAERS
13Adverse eventFAERS: 51US FAERS
14PancreatitisFAERS: 51US FAERS
15Chest PainFAERS: 41US FAERS
16NauseaFAERS: 41US FAERS
17DizzinessFAERS: 38US FAERS
18Drug ineffectiveFAERS: 34US FAERS
19HeadacheFAERS: 32US FAERS
20Back PainFAERS: 29US FAERS
21Blood cholesterol increasedFAERS: 27US FAERS
22Drug dose omissionFAERS: 26US FAERS
23MalaiseFAERS: 25US FAERS
24PruritusFAERS: 24US FAERS
25VomitingFAERS: 24US FAERS
26Alanine Aminotransferase IncreasedFAERS: 22US FAERS
27HepatitisFAERS: 20US FAERS
28AbasiaFAERS: 19US FAERS
29Abdominal PainFAERS: 19US FAERS
30Aspartate Aminotransferase IncreasedFAERS: 19US FAERS
31muscle injuryFAERS: 19US FAERS
32Inappropriate schedule of drug administrationFAERS: 18US FAERS
33Memory impairmentFAERS: 18US FAERS
34Neck PainFAERS: 18US FAERS
35AmnesiaFAERS: 17US FAERS
36Activities of daily living impairedFAERS: 16US FAERS
37ChromaturiaFAERS: 16US FAERS
38Feeling abnormalFAERS: 16US FAERS
39Musculoskeletal PainFAERS: 16US FAERS
40Blood creatinine increasedFAERS: 15US FAERS
41MyopathyFAERS: 14US FAERS
42PalpitationsFAERS: 14US FAERS
43PneumoniaFAERS: 14US FAERS
44CholelithiasisFAERS: 13US FAERS
45MyositisFAERS: 13US FAERS
46Product quality issueFAERS: 13US FAERS
47AnorexiaFAERS: 12US FAERS
48Weight decreasedFAERS: 12US FAERS
49jaundiceFAERS: 12US FAERS
50Coronary Artery DiseaseFAERS: 11US FAERS
51Medication ErrorFAERS: 11US FAERS
52ArthritisFAERS: 10US FAERS
53Joint swellingFAERS: 10US FAERS
54Wrong technique in drug usage processFAERS: 10US FAERS
55Abdominal discomfortFAERS: 9US FAERS
56AlopeciaFAERS: 9US FAERS
57ArthropathyFAERS: 9US FAERS
58CholecystitisFAERS: 9US FAERS
59ConstipationFAERS: 9US FAERS
60DehydrationFAERS: 9US FAERS
61Musculoskeletal stiffnessFAERS: 9US FAERS
62UrticariaFAERS: 9US FAERS
63Angina PectorisFAERS: 8US FAERS
64BlindnessFAERS: 8US FAERS
65Burning sensationFAERS: 8US FAERS
66Chest discomfortFAERS: 8US FAERS
67DementiaFAERS: 8US FAERS
68FlatulenceFAERS: 8US FAERS
69ThrombocytopeniaFAERS: 8US FAERS
70Wrong technique in product usage processFAERS: 8US FAERS
71Blood alkaline phosphatase increasedFAERS: 7US FAERS
72CataractFAERS: 7US FAERS
73Diabetes MellitusFAERS: 7US FAERS
74DiscomfortFAERS: 7US FAERS
75HypersensitivityFAERS: 7US FAERS
76Impaired work abilityFAERS: 7US FAERS
77Rotator cuff syndromeFAERS: 7US FAERS
78SyncopeFAERS: 7US FAERS
79TremorFAERS: 7US FAERS
80Acute myocardial infarctionFAERS: 6US FAERS
81Blood triglycerides increasedFAERS: 6US FAERS
82Joint stiffnessFAERS: 6US FAERS
83Product substitution issueFAERS: 6US FAERS
84SomnolenceFAERS: 6US FAERS
85Tooth LossFAERS: 6US FAERS
86Urinary tract infectionFAERS: 6US FAERS
87Visual disturbanceFAERS: 6US FAERS
88AphasiaFAERS: 5US FAERS
89Blood cholesterol abnormalFAERS: 5US FAERS
90Blood glucose increasedFAERS: 5US FAERS
91Bone painFAERS: 5US FAERS
92Cutis LaxaFAERS: 5US FAERS
93DeafnessFAERS: 5US FAERS
94Drug dispensing errorFAERS: 5US FAERS
95Hepatic necrosisFAERS: 5US FAERS
96HypothyroidismFAERS: 5US FAERS
97InfluenzaFAERS: 5US FAERS
98Pancreatic carcinomaFAERS: 5US FAERS
99Transaminases increasedFAERS: 5US FAERS
100AscitesFAERS: 4US FAERS
101AsthmaFAERS: 4US FAERS
102Blood creatine phosphokinase MB increasedFAERS: 4US FAERS
103DiplopiaFAERS: 4US FAERS
104DiverticulitisFAERS: 4US FAERS
105ErythemaFAERS: 4US FAERS
106Hepatitis BFAERS: 4US FAERS
107InflammationFAERS: 4US FAERS
108Low density lipoprotein increasedFAERS: 4US FAERS
109NeuralgiaFAERS: 4US FAERS
110OverdoseFAERS: 4US FAERS
111PancytopeniaFAERS: 4US FAERS
112Pharmaceutical product complaintFAERS: 4US FAERS
113Polymyalgia RheumaticaFAERS: 4US FAERS
114Product use issueFAERS: 4US FAERS
115SwellingFAERS: 4US FAERS
116Throat irritationFAERS: 4US FAERS
117ThrombosisFAERS: 4US FAERS
118Ventricular hypertrophyFAERS: 4US FAERS
119VertigoFAERS: 4US FAERS
120Visual ImpairmentFAERS: 4US FAERS
121Anaphylactic shockFAERS: 3US FAERS
122Aortic AneurysmFAERS: 3US FAERS
123AppendicitisFAERS: 3US FAERS
124Blood creatine phosphokinase abnormalFAERS: 3US FAERS
125Blood lactate dehydrogenase increasedFAERS: 3US FAERS
126BradycardiaFAERS: 3US FAERS
127Cardiac ArrestFAERS: 3US FAERS
128ChokingFAERS: 3US FAERS
129CryingFAERS: 3US FAERS
130Depression suicidalFAERS: 3US FAERS
131DiplegiaFAERS: 3US FAERS
132DiverticulumFAERS: 3US FAERS
133Drug prescribing errorFAERS: 3US FAERS
134Erectile dysfunctionFAERS: 3US FAERS
135Expired product administeredFAERS: 3US FAERS
136FibromyalgiaFAERS: 3US FAERS
137Flank PainFAERS: 3US FAERS
138Gait inabilityFAERS: 3US FAERS
139Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
140GastritisFAERS: 3US FAERS
141GastroenteritisFAERS: 3US FAERS
142Gastrointestinal PainFAERS: 3US FAERS
143General physical health deteriorationFAERS: 3US FAERS
144GoutFAERS: 3US FAERS
145HypotensionFAERS: 3US FAERS
146Intestinal ObstructionFAERS: 3US FAERS
147Joint InstabilityFAERS: 3US FAERS
148Leukocytoclastic vasculitisFAERS: 3US FAERS
149Low density lipoprotein abnormalFAERS: 3US FAERS
150LymphomaFAERS: 3US FAERS
151Maternal exposure during pregnancyFAERS: 3US FAERS
152Multiple MyelomaFAERS: 3US FAERS
153Muscle necrosisFAERS: 3US FAERS
154Muscle tightnessFAERS: 3US FAERS
155Myasthenia GravisFAERS: 3US FAERS
156PolymyositisFAERS: 3US FAERS
157Product physical issueFAERS: 3US FAERS
158Product taste abnormalFAERS: 3US FAERS
159Quality of life decreasedFAERS: 3US FAERS
160Renal cystFAERS: 3US FAERS
161Respiratory distressFAERS: 3US FAERS
162Restless Legs SyndromeFAERS: 3US FAERS
163SciaticaFAERS: 3US FAERS
164SepsisFAERS: 3US FAERS
165Therapeutic response unexpectedFAERS: 3US FAERS
166VasculitisFAERS: 3US FAERS
167Accidental overdoseFAERS: 2US FAERS
168Acute respiratory failureFAERS: 2US FAERS
169AgeusiaFAERS: 2US FAERS
170Amaurosis FugaxFAERS: 2US FAERS
171AngioedemaFAERS: 2US FAERS
172AngioplastyFAERS: 2US FAERS
173Atrial FibrillationFAERS: 2US FAERS
174Basal cell carcinomaFAERS: 2US FAERS
175BedriddenFAERS: 2US FAERS
176Blood bilirubin unconjugated increasedFAERS: 2US FAERS
177Blood creatine phosphokinase MB abnormalFAERS: 2US FAERS
178Blood iron decreasedFAERS: 2US FAERS
179Blood phosphorus decreasedFAERS: 2US FAERS
180Blood potassium decreasedFAERS: 2US FAERS
181Blood potassium increasedFAERS: 2US FAERS
182Blood triglycerides abnormalFAERS: 2US FAERS
183Blood urea increasedFAERS: 2US FAERS
184Bone erosionFAERS: 2US FAERS
185ChillsFAERS: 2US FAERS
186CholestasisFAERS: 2US FAERS
187Diabetes mellitus inadequate controlFAERS: 2US FAERS
188Drug administration errorFAERS: 2US FAERS
189Drug exposure during pregnancyFAERS: 2US FAERS
190Drug level increasedFAERS: 2US FAERS
191DysgeusiaFAERS: 2US FAERS
192DyspepsiaFAERS: 2US FAERS
193DysphemiaFAERS: 2US FAERS
194DysphoniaFAERS: 2US FAERS
195Economic problemFAERS: 2US FAERS
196Enzyme abnormalityFAERS: 2US FAERS
197EpistaxisFAERS: 2US FAERS
198Expired drug administeredFAERS: 2US FAERS
199Eye painFAERS: 2US FAERS
200Facial PainFAERS: 2US FAERS
201Feeling of body temperature changeFAERS: 2US FAERS
202Food AllergyFAERS: 2US FAERS
203Gastrointestinal ulcerFAERS: 2US FAERS
204HemiparesisFAERS: 2US FAERS
205High density lipoprotein increasedFAERS: 2US FAERS
206HypersomniaFAERS: 2US FAERS
207Impaired driving abilityFAERS: 2US FAERS
208Intentional product misuseFAERS: 2US FAERS
209Intracranial AneurysmFAERS: 2US FAERS
210Lactose IntoleranceFAERS: 2US FAERS
211Lichen PlanusFAERS: 2US FAERS
212Limb discomfortFAERS: 2US FAERS
213LipomaFAERS: 2US FAERS
214MalabsorptionFAERS: 2US FAERS
215Middle insomniaFAERS: 2US FAERS
216Muscle CrampFAERS: 2US FAERS
217Muscle FatigueFAERS: 2US FAERS
218Muscle strainFAERS: 2US FAERS
219Musculoskeletal chest painFAERS: 2US FAERS
220Musculoskeletal discomfortFAERS: 2US FAERS
221Neutrophil count decreasedFAERS: 2US FAERS
222NoduleFAERS: 2US FAERS
223Oropharyngeal painFAERS: 2US FAERS
224Pancreatic NeoplasmFAERS: 2US FAERS
225Peripheral swellingFAERS: 2US FAERS
226Post procedural complicationFAERS: 2US FAERS
227Product dose omissionFAERS: 2US FAERS
228Product label issueFAERS: 2US FAERS
229ProteinuriaFAERS: 2US FAERS
230Renal painFAERS: 2US FAERS
231Respiratory FailureFAERS: 2US FAERS
232Respiratory arrestFAERS: 2US FAERS
233Septic ShockFAERS: 2US FAERS
234Shoulder PainFAERS: 2US FAERS
235SinusitisFAERS: 2US FAERS
236Spinal column stenosisFAERS: 2US FAERS
237Stevens-Johnson SyndromeFAERS: 2US FAERS
238StressFAERS: 2US FAERS
239TachycardiaFAERS: 2US FAERS
240TensionFAERS: 2US FAERS
241Therapeutic response changedFAERS: 2US FAERS
242Vascular calcificationFAERS: 2US FAERS
243Walking aid userFAERS: 2US FAERS
244White blood cell count decreasedFAERS: 2US FAERS
245ovarian neoplasmFAERS: 2US FAERS
246treatment failureFAERS: 2US FAERS
247Abdominal symptomFAERS: 1US FAERS
248Accidental exposure to product packagingFAERS: 1US FAERS
249AcidosisFAERS: 1US FAERS
250AcneFAERS: 1US FAERS
251Acute Coronary SyndromeFAERS: 1US FAERS
252Acute kidney injuryFAERS: 1US FAERS
253AdenocarcinomaFAERS: 1US FAERS
254AgitationFAERS: 1US FAERS
255Angiogram abnormalFAERS: 1US FAERS
256Anticonvulsant drug level decreasedFAERS: 1US FAERS
257Aortic Valve StenosisFAERS: 1US FAERS
258AspergillosisFAERS: 1US FAERS
259AtaxiaFAERS: 1US FAERS
260Autoimmune PancreatitisFAERS: 1US FAERS
261Autoimmune hepatitisFAERS: 1US FAERS
262Autonomic neuropathyFAERS: 1US FAERS
263Axonal neuropathyFAERS: 1US FAERS
264Back disorderFAERS: 1US FAERS
265Bacteria blood identifiedFAERS: 1US FAERS
266Bile Duct StenosisFAERS: 1US FAERS
267Biliary ColicFAERS: 1US FAERS
268Bladder NeoplasmFAERS: 1US FAERS
269BlepharitisFAERS: 1US FAERS
270Blood amylase increasedFAERS: 1US FAERS
271Blood blisterFAERS: 1US FAERS
272Blood creatinine abnormalFAERS: 1US FAERS
273Blood electrolytes decreasedFAERS: 1US FAERS
274Blood glucose abnormalFAERS: 1US FAERS
275Blood magnesium decreasedFAERS: 1US FAERS
276Blood pressure fluctuationFAERS: 1US FAERS
277Blood urine presentFAERS: 1US FAERS
278BradyphreniaFAERS: 1US FAERS
279Breast CystFAERS: 1US FAERS
280BronchitisFAERS: 1US FAERS
281Bronchopulmonary diseaseFAERS: 1US FAERS
282BursitisFAERS: 1US FAERS
283Calcium deficiencyFAERS: 1US FAERS
284Cardiac DeathFAERS: 1US FAERS
285CardiomegalyFAERS: 1US FAERS
286Carotid artery occlusionFAERS: 1US FAERS
287Carotid bruitFAERS: 1US FAERS
288Cataract operationFAERS: 1US FAERS
289CellulitisFAERS: 1US FAERS
290Cerebral ArteriosclerosisFAERS: 1US FAERS
291ChemotherapyFAERS: 1US FAERS
292CholangitisFAERS: 1US FAERS
293Cluster HeadacheFAERS: 1US FAERS
294ColectomyFAERS: 1US FAERS
295Colon adenomaFAERS: 1US FAERS
296Corneal dystrophyFAERS: 1US FAERS
297Coronary angioplastyFAERS: 1US FAERS
298CyanosisFAERS: 1US FAERS
299CystFAERS: 1US FAERS
300Deafness NeurosensoryFAERS: 1US FAERS
301Deep Vein ThrombosisFAERS: 1US FAERS
302Dengue FeverFAERS: 1US FAERS
303Depressed moodFAERS: 1US FAERS
304DermatitisFAERS: 1US FAERS
305DermatomyositisFAERS: 1US FAERS
306Diabetic NephropathyFAERS: 1US FAERS
307DisabilityFAERS: 1US FAERS
308Disease complicationFAERS: 1US FAERS
309DisorientationFAERS: 1US FAERS
310Disseminated Intravascular CoagulationFAERS: 1US FAERS
311Drug ineffective for unapproved indicationFAERS: 1US FAERS
312Dry skinFAERS: 1US FAERS
313DysarthriaFAERS: 1US FAERS
314EczemaFAERS: 1US FAERS
315Electrocardiogram ST-T changeFAERS: 1US FAERS
316Embolic strokeFAERS: 1US FAERS
317EndometriosisFAERS: 1US FAERS
318EndophthalmitisFAERS: 1US FAERS
319EosinophiliaFAERS: 1US FAERS
320Exposure to chemical pollutionFAERS: 1US FAERS
321Eye inflammationFAERS: 1US FAERS
322FibrosisFAERS: 1US FAERS
323FormicationFAERS: 1US FAERS
324Frontotemporal dementiaFAERS: 1US FAERS
325Full blood count decreasedFAERS: 1US FAERS
326GastrectomyFAERS: 1US FAERS
327Gastric mucosal lesionFAERS: 1US FAERS
328Gastric pH decreasedFAERS: 1US FAERS
329Gastrointestinal carcinomaFAERS: 1US FAERS
330GlioblastomaFAERS: 1US FAERS
331GliomaFAERS: 1US FAERS
332GliosisFAERS: 1US FAERS
333Global AmnesiaFAERS: 1US FAERS
334GlossitisFAERS: 1US FAERS
335Granulomatous liver diseaseFAERS: 1US FAERS
336Grip strength decreasedFAERS: 1US FAERS
337Heat StrokeFAERS: 1US FAERS
338Hepatic cancer metastaticFAERS: 1US FAERS
339Hepatic dysplasiaFAERS: 1US FAERS
340Hepatitis B positiveFAERS: 1US FAERS
341Hepatitis CFAERS: 1US FAERS
342Hepatorenal SyndromeFAERS: 1US FAERS
343HepatotoxicityFAERS: 1US FAERS
344HydrocephalusFAERS: 1US FAERS
345HyperkeratosisFAERS: 1US FAERS
346Hypertensive crisisFAERS: 1US FAERS
347HypogonadismFAERS: 1US FAERS
348HypoventilationFAERS: 1US FAERS
349HysterectomyFAERS: 1US FAERS
350Idiosyncratic drug reactionFAERS: 1US FAERS
351ImmobileFAERS: 1US FAERS
352Immune thrombocytopenic purpuraFAERS: 1US FAERS
353Impaired self-careFAERS: 1US FAERS
354Inability to afford medicationFAERS: 1US FAERS
355Incorrect dose administeredFAERS: 1US FAERS
356Incorrect route of drug administrationFAERS: 1US FAERS
357InfectionFAERS: 1US FAERS
358Inflammatory marker increasedFAERS: 1US FAERS
359Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
360Intervertebral Disc DegenerationFAERS: 1US FAERS
361Joint Range of Motion DecreasedFAERS: 1US FAERS
362Laboratory test interferenceFAERS: 1US FAERS
363LaryngitisFAERS: 1US FAERS
364LaryngospasmFAERS: 1US FAERS
365LethargyFAERS: 1US FAERS
366Ligament ruptureFAERS: 1US FAERS
367Limb operationFAERS: 1US FAERS
368Lip and/or oral cavity cancerFAERS: 1US FAERS
369Lip swellingFAERS: 1US FAERS
370Lipase increasedFAERS: 1US FAERS
371Livedo ReticularisFAERS: 1US FAERS
372Loss of proprioceptionFAERS: 1US FAERS
373Lower respiratory tract infectionFAERS: 1US FAERS
374Lupus-like syndromeFAERS: 1US FAERS
375LymphadenopathyFAERS: 1US FAERS
376Mallory-Weiss SyndromeFAERS: 1US FAERS
377MastectomyFAERS: 1US FAERS
378Medical induction of comaFAERS: 1US FAERS
379Meniscus injuryFAERS: 1US FAERS
380Mental impairmentFAERS: 1US FAERS
381Mental status changesFAERS: 1US FAERS
382Metabolic acidosisFAERS: 1US FAERS
383MetaplasiaFAERS: 1US FAERS
384MetastasisFAERS: 1US FAERS
385MicroalbuminuriaFAERS: 1US FAERS
386MonoplegiaFAERS: 1US FAERS
387Multiple SclerosisFAERS: 1US FAERS
388Muscle enzyme increasedFAERS: 1US FAERS
389MyelofibrosisFAERS: 1US FAERS
390Myoglobin blood increasedFAERS: 1US FAERS
391NasopharyngitisFAERS: 1US FAERS
392NephritisFAERS: 1US FAERS
393Nerve injuryFAERS: 1US FAERS
394NeutropeniaFAERS: 1US FAERS
395Night sweatsFAERS: 1US FAERS
396Nipple painFAERS: 1US FAERS
397Ocular discomfortFAERS: 1US FAERS
398Ocular icterusFAERS: 1US FAERS
399OsteopeniaFAERS: 1US FAERS
400OsteoporosisFAERS: 1US FAERS
401OverweightFAERS: 1US FAERS
402PO2 decreasedFAERS: 1US FAERS
403Panic DisorderFAERS: 1US FAERS
404ParanoiaFAERS: 1US FAERS
405Partner stressFAERS: 1US FAERS
406PeriarthritisFAERS: 1US FAERS
407Peripheral artery stenosisFAERS: 1US FAERS
408Peripheral paralysisFAERS: 1US FAERS
409Personality ChangeFAERS: 1US FAERS
410PhotophobiaFAERS: 1US FAERS
411PoisoningFAERS: 1US FAERS
412PolyneuropathyFAERS: 1US FAERS
413PolyuriaFAERS: 1US FAERS
414Poor peripheral circulationFAERS: 1US FAERS
415Poor quality drug administeredFAERS: 1US FAERS
416Poor quality sleepFAERS: 1US FAERS
417Post procedural nauseaFAERS: 1US FAERS
418Prescribed overdoseFAERS: 1US FAERS
419Product availability issueFAERS: 1US FAERS
420Product comminglingFAERS: 1US FAERS
421Product container issueFAERS: 1US FAERS
422Product contaminationFAERS: 1US FAERS
423Product contamination chemicalFAERS: 1US FAERS
424Product expiration date issueFAERS: 1US FAERS
425Product identification number issueFAERS: 1US FAERS
426Product lot number issueFAERS: 1US FAERS
427Product use complaintFAERS: 1US FAERS
428Protein total decreasedFAERS: 1US FAERS
429Pulmonary EmbolismFAERS: 1US FAERS
430Renal ColicFAERS: 1US FAERS
431Renal cancer metastaticFAERS: 1US FAERS
432RetchingFAERS: 1US FAERS
433Reticulocyte count increasedFAERS: 1US FAERS
434Sexual DysfunctionFAERS: 1US FAERS
435ShockFAERS: 1US FAERS
436Sjogren's SyndromeFAERS: 1US FAERS
437Skeletal injuryFAERS: 1US FAERS
438Skin PapillomaFAERS: 1US FAERS
439Skin noduleFAERS: 1US FAERS
440SneezingFAERS: 1US FAERS
441SplenomegalyFAERS: 1US FAERS
442StomatitisFAERS: 1US FAERS
443SubileusFAERS: 1US FAERS
444Sudden Cardiac DeathFAERS: 1US FAERS
445Sudden deathFAERS: 1US FAERS
446Tablet physical issueFAERS: 1US FAERS
447Temperature intoleranceFAERS: 1US FAERS
448Terminal stateFAERS: 1US FAERS
449Therapy cessationFAERS: 1US FAERS
450Thermal burnFAERS: 1US FAERS
451Thrombocytopenic purpuraFAERS: 1US FAERS
452ThyroidectomyFAERS: 1US FAERS
453TinnitusFAERS: 1US FAERS
454Tongue bitingFAERS: 1US FAERS
455Tooth ErosionFAERS: 1US FAERS
456TransaminasesFAERS: 1US FAERS
457Ubiquinone decreasedFAERS: 1US FAERS
458Unevaluable eventFAERS: 1US FAERS
459Uterine RuptureFAERS: 1US FAERS
460Vascular painFAERS: 1US FAERS
461Vascular ruptureFAERS: 1US FAERS
462Ventricular FibrillationFAERS: 1US FAERS
463Vitamin D DeficiencyFAERS: 1US FAERS
464Wheelchair userFAERS: 1US FAERS
465colonoscopyFAERS: 1US FAERS
466nervous system disorderFAERS: 1US FAERS
467Chemical and Drug Induced Liver Injury18752389CTD
468Dyslipidemias19167588CTD
469Liver Failure, Acute18752389CTD
470Musculoskeletal Diseases19167588CTD
471Respiratory Tract Infections19167588CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.